PTC Therapeutics (PTCT) PT Lowered to $53 at JPMorgan, 'Late Stage Assets Remain Significantly Underappreciated'
Go back to PTC Therapeutics (PTCT) PT Lowered to $53 at JPMorgan, 'Late Stage Assets Remain Significantly Underappreciated'| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 68.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.68 | 52 Week High | $35.40 | |||
| Open | $68.68 | 52 Week Low | $4.03 | |||
| Day High | $68.68 | P/E | 7.31 | |||
| Day Low | $68.68 | EPS | $9.40 | |||
| Volume | 419 | |||||

